These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1684649)
1. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism. Brougham LR; Conway PG; Ellis DB Neuropharmacology; 1991 Oct; 30(10):1137-40. PubMed ID: 1684649 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum. Rivest R; Marsden CA Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367 [TBL] [Abstract][Full Text] [Related]
3. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons. Gudelsky GA; Nwajei EE; Defife K; Nash JF Synapse; 1992 Dec; 12(4):304-11. PubMed ID: 1361248 [TBL] [Abstract][Full Text] [Related]
4. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system. Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065 [TBL] [Abstract][Full Text] [Related]
5. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat. Szczepanik AM; Wilmot CA Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148 [TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism. Gray AM; Connick JH Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162 [TBL] [Abstract][Full Text] [Related]
7. Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study. Rivest R; Jolicoeur FB; Marsden CA Brain Res; 1991 Mar; 544(1):86-93. PubMed ID: 1677303 [TBL] [Abstract][Full Text] [Related]
8. Effects of amfonelic acid and GBR 12909 on the haloperidol- and clozapine-induced activation of dopamine neurons. Gudelsky GA; Nwajei EE; Defife K; Nash JF Psychopharmacol Bull; 1992; 28(3):275-9. PubMed ID: 1480731 [TBL] [Abstract][Full Text] [Related]
9. Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects. Lappalainen J; Hietala J; Koulu M; Syvälahti E Eur J Pharmacol; 1990 Nov; 190(3):403-7. PubMed ID: 2125564 [TBL] [Abstract][Full Text] [Related]
10. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Kitaichi K; Yamada K; Hasegawa T; Furukawa H; Nabeshima T Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732 [TBL] [Abstract][Full Text] [Related]
11. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin. Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342 [TBL] [Abstract][Full Text] [Related]
12. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Zetterström T; Sharp T; Ungerstedt U Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051 [TBL] [Abstract][Full Text] [Related]
13. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR; Johnson KM J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468 [TBL] [Abstract][Full Text] [Related]
14. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol. Rivest R; Marsden CA Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513 [TBL] [Abstract][Full Text] [Related]
15. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum. Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Commissiong JW; Slimovitch C; Toffano G Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171 [TBL] [Abstract][Full Text] [Related]
17. [Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats]. Bogdanov MB; Gaĭnetdinov RR; Kudrin VS; Medvedev OS; Val'dman AV Biull Eksp Biol Med; 1991 May; 111(5):505-7. PubMed ID: 1715214 [TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain. Nicolaou NM Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080 [TBL] [Abstract][Full Text] [Related]
19. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol. Karoum F; Egan MF Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156 [TBL] [Abstract][Full Text] [Related]
20. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine. Miller HH; Shore PA Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]